73
DAFTAR PUSTAKA
1. Perhimpunan Dokter Paru Indonesia. Pneumonia Komuniti: Pedoman
Diagnosis dan Penatalaksanaan di Indonesia. Jakarta: Balai Penerbit
FKUI; 2003.
2. Foy HM, Cooney MK, Allan I, et al. Rates of pneumonia during influenza
epidemics in Seattle, 1964 to 1975. JAMA 1979;241:253-8.
3. American Thoracic Society Board of Directors. Guidelines for the
management of adult with community-acquired pneumonia. Am J Respir
Crit Care Med. 2001; 163:1730-54.
4. Mendel LA, Wuderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean
NC, Dowell SF, et all. Infectious disease society of america / american
thoracic society consensus guidelines on the management of community-
acquired pneumonia in adults. Clinical Infectious Disease. 2007;44:527-
72.
5. Ewig S, Welte T. Evaluation of guidelines for community-acquired
pneumonia: a story of confounders, surprises and challenges. Eur Respir J.
2008;32:823-5.
6. Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ.
Practice guidelines for the management of community-acquired
pneumonia in adults. Infectious Diseases Society of America. Clin Infect
Dis. 2000;31:347-382.
74
7. Sectish TC, Prober CG. Pneumonia. Dalam Behrman RE, Kliegman RM,
Jenson HB. Penyunting Nelson. Textbook of pediatrics. Edisi ke-18
Philadelphia: WB Saunders. 2007;1795-800.
8. Suryanto A. Guideline on the management of severe community acquired
pneumonia and hospital acquired pneumonia. Dalam: Rahmatullah P,
Gasem H, Suntoko B, Purwoko Y, ed. Naskah lengkap chest and critical
care in internal medicine the second national scientific meeting of perpari
and the tenth national congress of perpari. Badan Penerbit Universitas
Diponegoro Semarang. 2008:69-80.
9. Gyssen IC, Van der Broek PJ. Optimizing antimicrobial therapy, a method
for antimicrobial drug use evaluation. J Antimicrob Chemother. 1992;
32:724-7.
10. Kristiyanto, Yusuf; Sianipar, Osman; Hisyam, Barmawi. Etiologi dan
sensitivitas terhadap antibiotik pada pasien pneumonia didapat di
masyarakat. Berkala Kesehatan Klinik vol. 11 no. 2. 2005: halaman 77.
11. Riquelme O R, Riquelme O M, Rioseco Z ML, et all. Etiology and
prognostics factors of community-acquired pneumonia among adults
patients admitted to a regional hospital in Chile. Rev Med Chil. 2006
May;134(5):597-605.
12. Charles PG, Whitby M, Fuller AJ, et all. The etiology of community-
acquired pneumonia in Australia: why penicillin plus doxycycline or a
macrolide is the most appropriate therapy. Clin Infect Dis. 2008 May
15;46(10):1513-21.
75
13. Goto H, Takeda H, Kawai S, et all. Susceptibilities of bacteria isolated
from patients with lower respiratory infectious diseases to antibiotics. Jpn
J Antibiot. 2008 Aug;61(4):209-40.
14. Liu Y, Chen M, Zhao T, et all. Causative agent distribution and antibiotic
therapy assessment among adult patients with community acquired
pneumonia in Chinese urban population. BMC Infect Dis. 2009 Mar
18;9:31.
15. Köksal I, Ozlü T, Bayraktar O, et all. Etiological agents of community-
acquired pneumonia in adult patients in Turkey. Tuberk Toraks.
2010;58(2):119-27.
16. Bao Z, Yuan X, Wang L, et all. The incidence and etiology of community-
acquired pneumonia in fever outpatients. Exp Biol Med (Maywood). 2012
Nov;237(11):1256-61.
17. Tao LL, Hu BJ, He LX, et all. Etiology and antimicrobial resistance of
community-acquired pneumonia in adult patients in China. Chin Med J
(Engl). 2012 Sep;125(17):2967-72.
18. Rahmatullah P. Pengelolaan Pneumoni Komunitas. Dalam: Padmomartono
FM, SUharti C, Gasem MH. Editors. Pertemuan Ilmiah Tahun VI PAPDI
Cabang Semarang. Badan Penerbit Universitas Diponegoro Semarang.
2002: 47-58
19. Rabbat A, Huchon GJ. Bacterial Pneumonia. Dalam: Albert RK, Spiro SG,
Jett JR, Clinical Respiratory Medicine, second edition. Ontario: Mosby.
2004; 23:273-287
76
20. Prasad R, Sanjay. Community Acquired Pneumonia: Evidence Based
Management. Pulmon. 2007; 9:1:4-12.
21. Mandell LA, Bartlett JG, Dowell SF, File TM Jr, Musher DM, Whitney C.
Infectious Diseases Society of America. Update of practice guidelines for
the management of community-acquired pneumonia in immunocompetent
adults. Clin Infect Dis. 2003; 37: 1405-1433
22. Niederman MS, Mandell LA, Anzueto A, Bass, JB, Broughton WA,
Campbell GD, et al; American Thoracic Society. Guidelines for the
management of adults with community-acquired pneumonia: Diagnosis,
assessment of severity, antimicrobial therapy, and prevention. Am J Respir
Crit Care Med. 2001; 163: 1730-1754
23. Holmes CL, Russel JA, Walley KR. Genetic polymorphism in sepsis and
septic shock. Chest 2003;124:1103-1115.
24. W S Lim, S V Baudouin, R C George, et all. BTS guidelines for the
management of community acquired pneumonia in adults: update 2009.
Thorax. 2009; 64: iii1-iii55
25. Mandell LA. Pneumonia, In : Fauci AS, Kasper DL, Longo DL, eds,
Harrison’s Principles of Internal Medicine, 17th ed, USA, The Mc Graw-
Hill companies Inc. 2008; chapter 251.
26. Sharpe BA, Flanders SA. Community Acquired Pneumonia: A practical
approach to management for hospital. Journal of Hospital Medicine vol 1,
no 3. 2006; 177-190
77
27. Handoyo, Thomas. Pneumonia severity index (PSI), CRB-65, dan CURB-
65 Untuk Memprediksi Ketahanan Hidup-30 Hari dan Mortalitas-30 Hari
Pada Penderita Community-acquired pneumonia (CAP) di RSUP dokter
Kariadi Semarang dan RSU Ketileng Kotamadia Semarang. Semarang:
Universitas Diponegoro. 2010.
28. Niederman MS. Pneumonia, Including Community-Acquired Pneumonia
and Nosocomial Pneumonia. In Crapo JD, Glassroth J, Karlinsky, King Jr.
TE, editors. Baum’s Textbook of Pulmonary Disease. Seventh Ed.
Lippincot Williams and Wilkins. 2004; 22:425-453.
29. Marrie TJ, Campbell GD, Walker DH, Low DE. Pneumonia. In: Kasper D,
Fauci A, Longo DL, Braunwald E, Hauser SL, Jameson JL, editors.
Harrison’s principle of internal medicine 16th. New York-Toronto: Mc
Graw Hill Health Profession Division; 2005. P 1528-38
30. Marston BJ, Plouffe JF, File TM Jr, et al.Incidence of community-acquired
pneumonia requiring hospitalization: results of a population-based active
surveillance study in Ohio. Arch Intern Med. 1997;157:1709-18
31. Amrita. Evaluasi Penggunaan Antibiotik Empirik pada Penderita
Community-acquired pneumonia (CAP) yang Dirawat di RSUP dokter
Kariadi Semarang. Semarang: Universitas Diponegoro. 2010
32. Pedoman Penggunaan Antibiotik RSUP Dokter Kariadi (2007)
33. Dagnew Mulat, Yismaw Gizachew, et all. Bacterial profile and
antimicrobial susceptibility pattern in septicemia suspected patients
78
attending Gondar University Hospital, Northwest Ethiopia. BMC Research
Notes. 2013, 6:283
34. Cham Gregory, Yan Sun, et all. Predicting Positive Blood Cultures in
Patients presenting with Pneumonia at an Emergency Department in
Singapore. Annals Academy of Medicine. 2009 June; Vol 38 No. 6
35. Hartzell Joshua D, Kim Andrew S, et all. Acinetobacter Pneumonia: A
Review. MedGen Med. 2007 Jul; 9(3): 4
36. Wilks David, Farrington Mark. The Infectious Disease Manual. Oxford:
Blackwell Science. 1995
37. Erdede M, Denizbasi A, Onur O, et all. Do we really need blood cultures
in treating patients with community-acquired pneumonia. Bratisi Lek Listy
2010; 111 (5):286-289
38. Froggat JW, Johnston JL, Galetto DW, et all. Antimicrobial resistance in
nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents
Chemother. 1989; 33 (4): 460-6
39. Wojtyczka Robert D, Orlewaska Kamila, et all. Biofilm Formation and
Antimicrobial Susceptibility of Staphylococcus epidermidis Strains from
Hospital Environment. Int. J. Environ. Res. Pubic Health. 2014, 11, 4619-
4633
40. Afshar Nima, Tabas Jeffrey, et all. Blood Cultures for Community
Acquired Pneumonia: Are They Worthy of Two Quality Measures? A
Systematic Review. Society of Hospital Medicine. 2009 February. Vol 4
no.2
79
41. TJ Marrie, M Poulin-Costello, et all. Etiology of community-acquired
pneumonia treated in an ambulatory setting. Respir Med. 2005 Jan;
99(1):60-5.
42. Mohsenifar Z, Chopra Sawtantra K, et all. Candida Pneumonia-Experience
With 20 Patients. West J Med. 1979 Sep;131:196-200
43. Freitas M, Castelo A, et all. Viridans streptococci causing community
acquired pneumonia. Arch Dis Child. Sep 2006; 91(9): 779-780
44. Eugenin Eliseo A. Community-acquired pneumonia infections by
Acinetobacter baumanii-How does alcohol impact the antimicrobial
functions of macrophages. Landes Bioscience. August 2013. Virulence
4:6, 435-436.
45. TJ Marrie, et all. Community-acquired pneumonia due to eschericia coli.
Clin Microbiol Infect. 1998 Feb; 4(12):717-723
46. Boyer Alexandre, Amadeo Brice, et all. Severe community-acquired
Enterobacter pneumonia: a plea for greater awareness of the concept of
health care associated pneumonia. BMC Infectious Diseases. 2011, 11:120
47. F Gantier, et all. Two cases of severe community-acquired pleural
pneumonia due to Streptococcus pyogenes. Press Med. 2003 May 24;
32(18): 839-42
80
48. Teng Lee-Jene, Yuan Ang, et all. Clinical and Microbiological
Characteristics of Rhizobium radiobacter Infections. Clinical Infectious
Disease. 2004; 149-53
49. MR Monteen, et all. Treatment of Chryseobacterium indolgenes
ventilator-associated pneumonia in a critically ill trauma patients. Ann
Pharmacother. 2013 Dec; 47(12): 1736-9
50. Leesik H, Ani U, Juhani A, et all. Microbial pathogens of adult community
acquired pneumonia in Southern Estonia. Medicina (Kaunas). 2006;
42(5):384-94.
51. Banu Asima, Kabbin Jyoti S, et all. Extraintestinal Infections due to
Escherichia coli: An emerging Issue. Journal of Clinical Diagnostic
Research. 2011 June. Vol 5(3); 486-490
52. I Reynauld, et all. A severe form of Chryseobacterium indolgenes
pneumonia in an immunocompetent patient. Med Mal Infect. 2007 Nov;
37(11):762-4
81
Lampiran 1. Ethical Clearance
82
Lampiran 2. Surat permohonan peminjaman rekam medik
83
Lampiran 3. Daftar tilik penelusuran rekam medik
Nama
Usia
Jenis Kelamin
No. CM
Spesimen
Metode
Kuman
sensitivitas antibiotik S / R
amikacin
amoxiclav AC
ampicil-sulbactam
cefepime
cefotaxime
cefoxitin
ciprofloxacin
chloramphenicol
cotrimoxazole
erythromycin
meropenem
moxifloxacin
piper + tazobactam
tetracyclin
sulbactam cefoperazone
ceftazidime
84
Lampiran 4. Dokumentasi penelitian
85
Lampiran 5. Biodata Mahasiswa
Identitas
Nama : Marcellinus Triyuono Dairo
NIM : 22010110120134
Tempat / tanggal lahir : Cirebon, 11 Januari 1992
Jenis Kelamin : Laki-laki
Alamat : Jl. Simega no.111 Kabupaten Cirebon, Jawa Barat
Nomor HP : 083878566383
E-mail : [email protected]
Riwayat Pendidikan Formal
1. SD Santa Maria Cirebon : 1998 - 2004
2. SMP Santa Maria Cirebon : 2004 - 2007
3. SMA Negeri 1 Kota Cirebon : 2007 - 2010
4. Fakultas Kedokteran Undip : 2010 -
Keanggotan Organisasi
1. BEM Kastrad Fakultas Kedokteran-Kedokteran Umum Undip tahun 2010